Bariatric Surgery Without the Bed: Same-Day Discharge, ERAS, and the ICU Question

The hospital stay that follows weight-loss surgery has been shrinking for a decade, and the newest numbers suggest that in some settings it is close to disappearing. Five papers published within the past three weeks — a ten-year enhanced-recovery cohort, a national registry analysis of discharge timing, two ambulatory case series and a centre that operates with no intensive care unit on site — circle a question that has as much to do with hospital architecture as with surgical technique. How much institution does a gastric sleeve or a gastric bypass actually need?

A decade of protocol, measured

The clearest long view comes from a single centre in Srinagar, India, where investigators tracked 250 consecutive laparoscopic sleeves and gastric bypasses across two five-year epochs and reported the results in Obesity Surgery on 5 October.

Mean length of stay fell from 2.8 days in 2016–2020 to 1.2 days in 2021–2025, a 57% reduction, while same-day discharge rose from 12% to 64% of patients. Measured compliance with enhanced-recovery (ERAS) protocol elements climbed from 58% to 89%, opioid consumption dropped by 72%, and major complications fell from five events (4.0%) to two (1.6%). Thirty-day readmissions moved from 3.2% to 2.4% — a difference the authors decline to treat as real.

That last detail is the interesting one. This is a prospective before-after cohort, not a randomized comparison, and the paper says so plainly: with two major complications in the second epoch, the study was underpowered for uncommon but consequential events. The authors describe their findings as support for feasibility rather than proof of safety — an unusually restrained framing for a field that often reads a shorter stay as an outcome in its own right.

The registry pushes back on day zero

Set against that trajectory is the largest dataset in the cluster: a retrospective analysis of the MBSAQIP registry covering adults who had a sleeve or a bypass between 2015 and 2019, published in Surgery for Obesity and Related Diseases, the journal of the American Society for Metabolic and Bariatric Surgery.

Its authors sorted patients by when they went home — same day, the next day, or later — and found that next-day discharge was associated with lower odds of death and of serious complications than same-day discharge. For gastric bypass, going home on postoperative day 1 meant roughly 75% lower odds of mortality and 60% lower odds of a Clavien-Dindo grade III or higher complication; for sleeve gastrectomy, 58% and 35%. Staying longer than a day carried lower mortality odds after bypass than same-day discharge, but no mortality advantage after sleeve — and sleeve patients kept in hospital actually had higher odds of a serious complication.

A registry association is not a causal finding, and this one rests on accredited American centres and on data that are now several years old, which is a long time in a specialty moving this quickly. It is also the only analysis here with enough patients to see rare events, and it points the other way from the marketing.

Two ambulatory series, read two ways

A private practice in the United States reports 2,144 procedures performed between 2015 and 2023, overwhelmingly sleeves, under an eligibility rule that capped body mass index at 55 for men and 60 for women and excluded anyone with prior major abdominal surgery. Complications including hospital admissions totalled 25 cases, or 1.17%; in 92% of patients nothing was recorded at all. The reporting is descriptive — no significance testing — and the complication window closes at 72 hours. Screening rules like these are where most ambulatory programmes quietly set their risk, and the thresholds are still written in BMI terms, which is what our BMI calculator attempts to translate for a general reader.

From a regional hospital in France comes the counterweight: 69 ambulatory cases, mostly sleeves, mean BMI 40.7, selected under national HAS criteria. Nearly a third — 29% — converted to an inpatient stay, most often for unrelieved pain or food intolerance; eight patients presented to an emergency department and seven were readmitted. There were no deaths. Mild obstructive sleep apnoea was independently associated with conversion, a small result that nonetheless illustrates how much of ambulatory success is patient selection rather than surgical technique.

The building without an ICU

The most architectural question was asked by a group in Warsaw in Surgical Endoscopy on 8 October: if a centre has no intensive care unit on site, only a predefined escalation and transfer protocol, what actually happens to elective metabolic and bariatric surgery?

Across 2022–2025, 351 sleeve and bypass patients were compared with 714 elective laparoscopic cholecystectomies performed in the same environment. Thirty-day complication rates were 4.27% and 3.64%. No bariatric patient required intensive care — 0 of 351 — which the authors translate carefully into an upper 95% confidence bound of 1.05%, meaning the data are compatible with rare critical-care need rather than with its absence. Two gallbladder patients did need ICU, both for pancreatitis. All five reoperations in the bariatric group were for bleeding, none met transfer criteria, and nobody died.

The paper closes with a warning aimed at exactly the wrong lesson: its findings, the authors write, “should not be generalized to accreditation policy.” Structural requirements for centre designation exist because zero events in 351 patients is not the same thing as zero risk.

Where that leaves the question

The direction of travel is consistent — shorter stays, more day-case pathways, protocols that make an overnight admission a choice rather than a rule. The evidence behind it is not. Two single-centre series, one before-after cohort and one registry analysis, all observational, all shaped by who was selected for the lighter-touch pathway in the first place.

The design that could settle it is a familiar one. The LABS study, funded by NIDDK, was built to measure 30-day harms across a broad, non-selected surgical population; the LABS archive on this site documents that design and remains a useful benchmark for what a properly powered safety baseline looks like.

What the current literature supports is narrower than the enthusiasm around it: selected patients, at centres with an explicit escalation plan, can go home faster than they did ten years ago. What it does not yet support is the assumption that the bed — or the ICU down the corridor — was never doing any work. Our earlier review of readmission drivers after bariatric surgery found dehydration and acute kidney injury behind 28% of 30-day readmissions in a 1.46-million-patient MBSAQIP analysis. Compressing the stay does not remove that risk; it moves the monitoring to a patient’s phone and the emergency department’s front door.